ESI Element Solutions Inc
Miscellaneous Chemical Products · NYSE · SEC CIK 1590714 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY39.6%
TTM net income YoY-14.4%
TTM EPS YoY-14.1%
Revenue 3-yr CAGR14.4%
Net income 3-yr CAGR56.3%
Margins
Gross margin36.6%
Operating margin11.7%
Net margin5.9%
FCF margin5.2%
EBITDA margin14.9%
Returns
ROE7.4%
ROA3.8%
ROIC (approx.)6.3%
Asset turnover0.64x
Leverage & solvency
Liabilities / assets50.7%
Debt / equity0.72x
Current ratio2.78x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.38x
Accruals ratio-1.4%
Payout ratio38.4%
Capex / revenue2.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.55B | $2.46B |
| Cost of revenue | $1.48B | $1.42B |
| Gross profit | $1.07B | $1.04B |
| R&D expense | $67.60M | $63.00M |
| SG&A expense | $660.70M | $628.80M |
| Operating income | $342.20M | $343.90M |
| Pretax income | $265.60M | $287.70M |
| Income tax | $74.60M | $44.80M |
| Net income | $190.80M | $244.20M |
| EBITDA | $493.40M | $501.50M |
| EPS (basic) | 0.79 | 1.01 |
| EPS (diluted) | 0.79 | 1.01 |
| Dividends declared per share | 0.32 | 0.32 |
| Weighted avg. shares (diluted) | 242.40M | 242.60M |
| Banking | ||
| Net interest income | -$53.40M | -$56.30M |
| Balance sheet | ||
| Cash & equivalents | $626.50M | $359.40M |
| Receivables | $517.70M | $439.60M |
| Inventory | $294.70M | $246.20M |
| Current assets | $1.58B | $1.27B |
| PP&E, net | $319.60M | $276.80M |
| Goodwill | $2.24B | $2.13B |
| Intangibles | $657.20M | $732.00M |
| Total assets | $5.10B | $4.87B |
| Current liabilities | $429.90M | $379.70M |
| Short-term debt | $0 | $10.40M |
| Long-term debt | $1.63B | $1.81B |
| Total debt | $1.63B | $1.82B |
| Total liabilities | $2.41B | $2.48B |
| Shareholders' equity | $2.67B | $2.38B |
| Net debt | $999.40M | $1.46B |
| Cash flow statement | ||
| Operating cash flow | $289.80M | $362.00M |
| Capital expenditure | $62.20M | $68.40M |
| Free cash flow | $227.60M | $293.60M |
| Investing cash flow | $286.10M | -$73.80M |
| Financing cash flow | -$320.40M | -$206.60M |
| Depreciation & amortization | $151.20M | $157.60M |
| Stock-based compensation | $59.10M | $14.80M |
| Dividends paid | $77.80M | $78.20M |
| Share buybacks | $25.00M | $0 |
Free plan shows the latest 2 periods; Pro shows all 14 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.